ALLIANCE-MM1MDS-A01
Phase II
OPEN TO ACCRUAL
A Randomized Phase II Trial of Enasidenib-Based Therapies Versus Cedazuridine-Decitabine in Higher-Risk IDH2-Mutated Myelodysplastic Syndrome: A MyeloMATCH Sub-Study
DISC-0974-102
Phase I/II
OPEN TO ACCRUAL
A Phase 1b/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DISC-0974 in Participants with Myelofibrosis or Myelodysplastic Syndrome and Anemia
IIT-GURU-IADADEMSTAT-MDS
Phase I
OPEN TO ACCRUAL
Phase I Study of Iadademstat with Hypomethylating Agent in Patients with Myelodysplastic Syndrome
TAIHO-ASTX030-01
Phase II/III
OPEN TO ACCRUAL
A Multi-Phase, Pharmacokinetics, Safety, and Efficacy Study of ASTX030 (Azacitidine and Cedazuridine) as Monotherapy in Subjects with Myeloid Neoplasm or in Combination with Venetoclax in Subjects with AML (AZTOUND Study)